The Frequency and Prognosis of ATM Mutations in Chinese Non-Small-Cell Lung Cancer Patients

被引：1
作者：
Han, C. [1 ]
Xu, C. [2 ]
Wang, W. [3 ]
Zhang, Q. [4 ]
Zhuang, W. [2 ]
Zhu, Y. [5 ]
Huang, Y. [2 ]
Chen, Y. [2 ]
Chen, G. [2 ]
Fang, M. [3 ]
Lv, T. [6 ]
Song, Y. [7 ]
机构：
[1] Luan Peoples Hosp, Luan, Peoples R China
[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[4] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[6] Jinling Hosp, Resp, Nanjing, Jiangsu, Peoples R China
[7] Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Non-small-cell lung cancer; Prognosis; ATM mutation;
D O I：
10.1016/j.jtho.2018.08.706
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-25
引用
收藏
页码：S521 / S521
页数：1
相关论文
共 50 条
  • [31] Mutational Subtypes and Prognosis of East Asian Non-Small-Cell Lung Cancer Harboring NF2 Mutations
    Miao, L.
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Wang, G.
    Wang, Q.
    Song, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1216 - S1216
  • [32] Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer
    Yamagata, Akira
    Yokoyama, Toshihide
    Fukuda, Yasushi
    Ishida, Tadashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (02) : 251 - 258
  • [33] Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
    Tamiya, Akihiro
    Koh, Yasuhiro
    Isa, Shun-ichi
    Kubo, Akihito
    Ando, Masahiko
    Saka, Hideo
    Yoshimoto, Naoki
    Takeo, Sadanori
    Adachi, Hirofumi
    Tagawa, Tsutomu
    Kawashima, Osamu
    Yamashita, Motohiro
    Kataoka, Kazuhiko
    Takenoyama, Mitsuhiro
    Takeuchi, Yukiyasu
    Watanabe, Katsuya
    Matsumura, Akihide
    Kawaguchi, Tomoya
    CANCER MEDICINE, 2020, 9 (07): : 2343 - 2351
  • [34] Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer
    Akira Yamagata
    Toshihide Yokoyama
    Yasushi Fukuda
    Tadashi Ishida
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 251 - 258
  • [35] The Molecular Spectrum of NF1 Variants in Chinese Non-Small-Cell Lung Cancer Patients
    Zhang, Q.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Zhu, Y.
    Huang, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S515 - S515
  • [36] ROS1 fusions in Chinese patients with non-small-cell lung cancer
    Cai, W.
    Li, X.
    Su, C.
    Fan, L.
    Zheng, L.
    Fei, K.
    Zhou, C.
    Manegold, C.
    Schmid-Bindert, G.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1822 - 1827
  • [37] Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
    Hailiang Ran
    Jie Ma
    Le Cai
    Hai Zhou
    Zhongqin Yuan
    Ying Chen
    Wei Chang
    Yunchao Huang
    Yuanyuan Xiao
    BMC Cancer, 22
  • [38] Treatment and prognosis of advanced stage non-small-cell lung cancer
    Ben Abdallah, F. Chermiti
    Ben Ali, G.
    Boudaya, M. Sadok
    Mlika, M.
    Chtourou, A.
    Taktak, S.
    Ben Kheder, A.
    REVUE DES MALADIES RESPIRATOIRES, 2014, 31 (03) : 214 - 220
  • [39] Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
    Ran, Hailiang
    Ma, Jie
    Cai, Le
    Zhou, Hai
    Yuan, Zhongqin
    Chen, Ying
    Chang, Wei
    Huang, Yunchao
    Xiao, Yuanyuan
    BMC CANCER, 2022, 22 (01)
  • [40] Value of circular RNA 0007385 in disease monitoring and prognosis estimation in non-small-cell lung cancer patients
    Lin, Yijian
    Su, Weiming
    Lan, Guocui
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (08)
12345